key: cord-0313426-0cnr95i8
authors: Hussey, H.; Davies, M.-A.; Heekes, A.; Williamson, C.; Valley-Omar, Z.; Hardie, D. R.; Korsman, S.; Doolabh, D.; Preiser, W.; Maponga, T.; Iranzadeh, A.; Wasserman, S.; Schrueder, N.; Boloko, L.; Raubenheimer, P.; Symons, G.; Parker, A.; Viljoen, A.; Cohen, C.; JASSAT, W.; Lessels, R.; Wilkinson, R. J.; Boulle, A.; Hsiao, N.-y. M.
title: Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy
date: 2021-10-26
journal: nan
DOI: 10.1101/2021.10.23.21265412
sha: f6cc71526a3f4415b5da6539a29bbb4491a499a6
doc_id: 313426
cord_uid: 0cnr95i8

A novel proxy for the Delta variant, RNA-dependent RNA polymerase target delay in the Seegene AllplexTM 2019-nCoV PCR assay, was associated with higher mortality (adjusted Odds Ratio 1.45 [95%CI 1.13-1.86]), compared to presumptive Beta infection, in the Western Cape, South Africa (April-July 2021). Prior diagnosed infection and vaccination were protective.

To date, the Western Cape Province of South Africa, has experienced three large waves of SARS-CoV-2 infections. The first wave caused by early ancestral clades of SARS-CoV-2 peaked in June 2020, the second wave with the Beta variant (B.1.351) peaked in December 2020 and the third most recent wave caused by the Delta variant (B.1.617.2) peaked in August 2021 (1) .

Delta has become the dominant variant globally, and its increased clinical severity compared to other variants is suspected, although not fully documented or understood (2) (3) (4) (5) (6) . Relatively high vaccination coverage, however, complicates the interpretation of these findings. Delta has also mostly been compared to the Alpha variant, and not within a sub-Saharan African setting.

The start of the third wave of COVID-19 in the Western Cape Province was characterized by a rapid transition from the previously dominant Beta variant to Delta (1) . We used a novel proxy marker for Delta, namely RNAdependent RNA polymerase (RdRp) target delay (RTD) in PCR positive samples, to assess mortality associated with Delta, compared to Beta, in our population which had relatively low levels of vaccine coverage as well as a high prevalence of comorbidities, including HIV and tuberculosis.

RTD, defined as a difference in cycle threshold value of >3.5 in the RdRp relative to E gene target in the Seegene Allplex TM 2019-nCoV PCR assay, has recently been described (7) . This phenomenon is due to the G15451A mutation found in Delta, resulting in a RdRp primer mismatch. When evaluated against genomic data, this method had a sensitivity of 93.6% and specificity of 89.7% in detecting Delta (7) .

We included all COVID-19 cases diagnosed on the Seegene Allplex TM 2019-nCoV diagnostic PCR assay in the Western Cape public sector from 1 April to 31 July 2021, a period when both Beta and Delta were cocirculating (Appendix Figure 1 ). Alpha and non-variant of concern lineages accounted for a negligible number of infections at this time (1) . Follow-up ended on 31 August 2021. Approximately 70% of the Western Cape population uses the public sector for health services and the Western Cape Provincial Health Data Centre . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted October 26, 2021. ; https://doi.org/10.1101/2021.10.23.21265412 doi: medRxiv preprint (PHDC) collates all available electronic health data on these patients. Use of this data in COVID-19 analyses has been previously described (8) . COVID-19 deaths were defined as deaths within 28 days of diagnosis of COVID-19 or 14 days after discharge from hospital (where hospital admission occurred within 21 days of the COVID-19 diagnosis), without a non-COVID-19 cause of death recorded. Out-of-facility deaths were determined by civil identifier linkage of patients with COVID-19 diagnoses to the national population register.

We undertook logistic regression to determine the association between RTD and mortality, adjusted for age, Patients were deemed partially vaccinated from the day after their (first) vaccine dose until meeting criteria for complete vaccination.

The study was approved by the University of Cape Town Research Ethics Committee (HREC 460/2020).

We included 11 355 cases tested using the Seegene Allplex TM assay, which were 22% of all positive test results in the province in that time period (Appendix Table 1 ). The median age was 43 years (interquartile range [IQR] 32-55) and 44% were male. RTD was present in 9106 (80%) ( Table 1) . Patient characteristics were similar in those with and without RTD. There was, however, a difference in cycle threshold (Ct) values (average of the E and N gene targets); those with RTD had lower median Ct values (26.1, IQR 22.2-30.9, vs 32.7 IQR 25.6-37.6).

There were 700 deaths altogether, with a case fatality rate of 6.3% in those with RTD, compared to 5.8% in those without. After adjusting for all covariates RTD was significantly associated with death among cases . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 26, 2021. Table 2 ). In a stratified analysis the association between RTD and death was similar in both those aged <50 and ≥50 Table 2 ).

RTD, a proxy marker for the Delta variant, was associated with an increased risk for death compared to presumptive Beta variant infection, while prior diagnosed infection (with first infection in the second wave) and vaccination were strongly protective.

The increased transmissibility of Delta is well established, and may be due to its higher viral load (6) . In our analysis, specimens with RTD had lower Ct values than those without, suggesting a higher viral load. This, along with immune evasion by Delta, could contribute to the increased disease severity seen (9) . Nonetheless, our results need to be interpreted in the context of our setting where not all COVID-19 cases would have accessed testing. Delta often results in mild symptoms, and during wave surges, as was the case from 15 June 2021 until the end of the analysis period, in the public sector only those aged ≥45 years or with comorbidities or requiring hospital admission would be tested. The interpretation of our results is therefore that among those who access a PCR test, the Delta variant is associated with worse outcomes. While it is unclear if this finding can be extrapolated to all those with COVID-19 in our setting, similar findings from countries with more widespread testing support the increased clinical severity of Delta. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) (10) . Since most severe COVID-19 cases would be in unvaccinated people, differences between the vaccinated and the unvaccinated population might confound associations with variant infection and disease severity. In contrast, in the Western Cape by 31 July 2021, only 5.0% of all adults, mostly in older age groups, were fully vaccinated (10) . In addition, most of these studies compared the outcomes of Delta to Alpha. The Alpha variant has been shown to have worse clinical outcomes compared to wild-type, with an aHR for death of 1.73 (95%CI 1.41 -2.13) (11) .

This study has several limitations. First, we could only include cases tested on the Seegene Allplex TM 2019-nCoV assay, excluding cases diagnosed by other PCR methods or antigen testing. However, the included cases are mostly representative of all diagnosed PCR cases in the Western Cape (Appendix Table 1 ). Second, while RTD is a reliable proxy marker for Delta, it is not as accurate as whole genome sequencing, and misclassification may have diluted the effect of Delta. Third, we could only assess the effect of prior laboratory-confirmed COVID-19 infection and seroprevalence studies suggest considerably higher numbers were infected, even after the first wave, and that prior infection prevalence differed by sub-district of residence (12) . While we did adjust for sub-district, the absence of a protective effect of prior infection in the first wave may be due to insufficient numbers of those infections being diagnosed. Finally, although we adjusted for COVID-19 hospital admissions to account for escalating service pressure during the wave surge, we could not adjust for non-COVID-19 admissions that might have added to pressure on facilities and contributed to mortality.

Conclusion RTD, a useful proxy for infection with Delta, is associated with an increased risk of mortality amongst those who were tested for COVID-19 in our setting.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 26, 2021. ; https://doi.org/10.1101/2021.10.23.21265412 doi: medRxiv preprint https://www.nicd.ac.za/wp-content/uploads/2020/09/COVID-19-Special-Public-Health-Surveillance-Bulletin_Issue-5.pdf . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 26, 2021. ; https://doi.org/10.1101/2021.10.23.21265412 doi: medRxiv preprint Tables   Table 1: . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted October 26, 2021. ;

Tracking SARS-COV-2 variants -15

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

Hospitalisation associated with SARS-CoV-2 delta variant in Denmark

Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta)

Progressive Increase in Virulence of Novel SARS-CoV-2 Variants in Ontario, Canada. medRxiv

Risk assessment for SARS-CoV-2 variant: Delta

Reduced amplification efficiency of the RNA-dependent-RNA-polymerase (RdRp) target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests. medRxiv Prepr Serv Heal Sci

Risk factors for COVID-19 death in a population cohort study from the Western Cape Province

The biological and clinical significance of emerging SARS-CoV-2 variants

A global database of COVID-19 vaccinations

Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England

SARS-CoV-2 seroprevalence in the Cape Town metropolitan sub-districts after the peak of infections. Covid-19 Spec Public Heal Surveill Bull

Appendix: Table 2   Table 2 : Logistic regression for outcome of death in a) all positive Seegene Allplex TM cases, as per the original analysis; b) restricted only to those admitted to hospital; c) stratified by age into those aged under 50 and those aged 50 years.